Biomolecules and ATMPs

Biomolecules and ATMPs
Product Description

Biomolecules like antibodies have revolutionized the pharmaceutical industry during the last decade and new products (e.g. Advanced Therapy Medicinal Products – ATMPs) are evolving in clinical studies and on the market. Tentamus Pharma Labs are among the leaders of analytical support for these product categories. We work on new biologic entities as well as biosimilars with customers around the globe, helping them to reach market approval as fast as possible. A broad portfolio of analytical equipment and methods is available to support your ideas in this highly complex field. In addition we can offer consultancy services for biosimilars and biopharmaceuticals (e.g. market analyses, regulatory requirements). Contact us and arrange a meeting with our experts to learn more about our capabilities.

Tentamus Pharma and Med GmbH

  • DE
  • 2017
    On CPHI since
Company types
Contract Service
Specifications
  • Supplied from
    Austria; Germany; Israel; United Kingdom

Tentamus Pharma and Med GmbH

  • DE
  • 2017
    On CPHI since
Company types
Contract Service

More Products from Tentamus Pharma and Med GmbH (2)

  • Pharmaceutical Products

    Product Pharmaceutical Products

    Bringing a pharmaceutical product to the market entails many complex, time consuming and expensive activities. Analytical expertise is a cornerstone in this development process. Tentamus Pharma Labs can support our customers throught the entirety of the development process and commercialization by prov...
  • Medical Devices

    Product Medical Devices

    The EU Medical Device Regulation (MDR) requires a more stringent characterization of products in the Medical Device field. The MDR is madatory for all new products and existing products have to comply by May 26th 2020. Tentamus Pharma Labs are equipped to support you in fulfilling MDR requirements. Bio...